Search

Marc J Gurwith

from Los Altos Hills, CA
Age ~84

Marc Gurwith Phones & Addresses

  • 13157 La Paloma Rd, Los Altos Hills, CA 94022 (650) 917-9194 (650) 949-1045
  • 13517 La Paloma Rd, Los Altos, CA 94022
  • Alexandria, VA
  • Encinitas, CA
  • Eugene, OR
  • Sunriver, OR
  • Washington, DC
  • Palo Alto, CA
  • Staten Island, NY
  • Santa Clara, CA
  • Woodside, CA
  • San Mateo, CA
  • 13157 La Paloma Rd, Los Altos, CA 94022 (650) 793-8233

Work

Position: Medical Professional

Education

School / High School: Harvard Medical School 1965

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Infectious Disease, 1980

Emails

Specialities

Infectious Disease Medicine • Medical Microbiology

Professional Records

License Records

Marc Joseph Gurwith

Address:
Los Altos, CA 94022
License #:
MD031400E - Active
Category:
Medicine
Type:
Medical Physician and Surgeon

Medicine Doctors

Marc Gurwith Photo 1

Dr. Marc J Gurwith, Menlo Park CA - MD (Doctor of Medicine)

View page
Specialties:
Infectious Disease Medicine
Medical Microbiology
Address:
1100 Alma St Suite 109, Menlo Park, CA 94025
(650) 823-1548 (Phone)

1355 Bogue St Suite B220, East Lansing, MI 48824
Certifications:
Infectious Disease, 1980
Internal Medicine, 1973
Medical Microbiology, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1965
Medical School
Stanford
Graduated: 1965
Marc Gurwith Photo 2

Marc Joseph Gurwith, Menlo Park CA

View page
Specialties:
Infectious Disease Specialist
Address:
1100 Alma St, Menlo Park, CA 94025

Business Records

Name / Title
Company / Classification
Phones & Addresses
Marc Gurwith
CTO
Vaxgen Inc
Nonclassifiable Establishments · Pharmaceutical Preparation Manufacturing · Offices of Physicians (except Mental Health Specialists)
1000 Marina Blvd, Brisbane, CA 94005
(650) 624-1000, (650) 624-1087
Marc Gurwith
Medical Doctor, Principal
Dorothy Gurwith
Business Services at Non-Commercial Site
13157 Ln Paloma Rd, Los Altos, CA 94022
Marc Gurwith
Exec VP/Chief Medica
PaxVax, Inc.
Biotechnology · Commercial Physical Research
900 Veterans Blvd SUITE 500, Redwood City, CA 94063
Redwood City, CA 94063
3985 Sorrento Vly Blvd, San Diego, CA 92121
1100 Alma St, Menlo Park, CA 94025
(858) 450-9595, (650) 847-1162

Publications

Us Patents

Dhea Composition And Method

View page
US Patent:
7045513, May 16, 2006
Filed:
Mar 16, 2000
Appl. No.:
09/526802
Inventors:
Jagdish Parasrampuria - Bridgewater NJ, US
Maxine B. Yonker - Emerald Hills CA, US
Kenneth E. Schwartz - San Mateo CA, US
Marc J. Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/56
US Classification:
514170, 514169, 514177, 514178, 514180
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.

Treatment Of Sle With Dehydroepiandrosterone

View page
US Patent:
20030181435, Sep 25, 2003
Filed:
Jan 8, 2003
Appl. No.:
10/340267
Inventors:
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc.
International Classification:
A61K031/57
US Classification:
514/178000
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.

Dhea Composition And Method

View page
US Patent:
20060234992, Oct 19, 2006
Filed:
Mar 21, 2006
Appl. No.:
11/387111
Inventors:
Jagdish Parasrampuria - Bedminster NJ, US
Maxine Yonker - Emerald Hills CA, US
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
International Classification:
A61K 31/57
US Classification:
514177000
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.

Treatment Of Sle With Dehydroepiandrosterone

View page
US Patent:
6552010, Apr 22, 2003
Filed:
Nov 10, 2000
Appl. No.:
09/710754
Inventors:
Kenneth E. Schwartz - San Mateo CA
Marc J. Gurwith - Los Altos CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 3156
US Classification:
514177, 514170, 514171
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
Marc J Gurwith from Los Altos Hills, CA, age ~84 Get Report